How subtle differences in MHC class II affect the severity of experimental myasthenia gravis

Clinical Immunology and Immunopathology

Volumn 86, Issue 1, 1998, Pages 45-58

  Yang, Bingzhi ^a   McIntosh, Kevin R ^a   Drachman, Daniel B ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINERGIC RECEPTOR; CHOLINERGIC RECEPTOR ANTIBODY; INTERLEUKIN 2; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; T LYMPHOCYTE RECEPTOR;

AMINO ACID SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN PRESENTING CELL; ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; IMMUNOMODULATION; IMMUNOPATHOGENESIS; MOUSE; MYASTHENIA GRAVIS; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; T LYMPHOCYTE RECEPTOR GENE; TORPEDO CALIFORNICA;

EID: 0031963333     PISSN: 00901229     EISSN: None     Source Type: Journal    
DOI: 10.1006/clin.1997.4451     Document Type: Article

References (61)

1. Drachman D. B. Myasthenia gravis. N. Engl. J. Med. 330:1994;1797-1810.
2. Drachman D. B., Adams R. N., Stanley E. F., Pestronk A. Mechanisms of acetylcholine receptor loss in myasthenia gravis. J. Neurol. Neurosurg. Psychiat. 43:1980;601-610.
3. Drachman D. B., Adams R. N., Josifek L. F., Self S. G. Functional activities of autoantibodies to acetylcholine receptors and the clinical severity of myasthenia gravis. N. Engl. J. Med. 307:1982;769-775.
4. Engel A. G., Arahata K. The membrane attack complex of complement at the endplate in myasthenia gravis. Ann. NY. Acad. Sci. 505:1987;326-332.
5. Lennon V. A., Lindstrom J. M., Seybold M. E. Experimental autoimmune myasthenia gravis: cellular and humoral immune responses. Ann. NY. Acad. Sci. 274:1976;283-299.
6. Hohlfeld R., Toyka K. V., Michels M., Heininger K., Conti-Tronconi B., Tzartos S. J. Acetylcholine receptor-specific human T-lymphocyte lines. Ann. NY. Acad. Sci. 505:1987;27-38.
7. Melms A., Chrestel S., Schalke B. C., Wekerle H., Mauon A., Ballivet M., Barkas T. Autoimmune T lymphocytes in myasthenia gravis: Determination of target epitopes using T lines and recombinant products of the mouse nicotinic acetylcholine receptor gene. J. Clin. Invest. 83:1989;785-790.
8. Newsom-Davis J., Harcourt G., Sommer N., Beeson D., Willcox N., Rothbard J.-B. T Cell reactivity in myasthenia gravis. J. Autoimmun. 2:1989;101-108.
9. +. J. Immunol. 144:1990;1711-1720.
10. Patrick J., Lindstrom J. Autoimmune response to acetylcholine receptor. Science. 180:1973;871-872.
11. Lambert E. H., Lindstrom J. M., Lennon V. A. End-plate potentials in experimental autoimmune myasthenia gravis in rats. Ann. NY. Acad. Sci. 274:1976;300-318.
12. Penn A. S., Chang H. W., Lovelace R. E., Niemi W., Miranda A. Antibodies to acetylcholine receptors in rabbits: Immunochemical and electrophysiological studies. Ann. NY. Acad. Sci. 274:1976;354-376.
13. Berman P. W., Patrick J., Heinemann S., Klier F. G., Steinbach J. H. Factors affecting the susceptibility of different strains of mice to experimental myasthenia gravis. Ann. NY. Acad. Sci. 377:1981;237-257.
14. Fuchs S., Neva D., Tarrab-Hazdai R., Yaar F. Strain differences in the autoimmune response of mice to acetylcholine receptors. Nature. 263:1976;329-330.
15. Christadoss P., Lennon V. A., Krco C. J., Lambert E. H., David C. S. Genetic control of autoimmunity to acetylcholine receptors: role of Ia molecules. Ann. NY. Acad. Sci. 377:1981;258-277.
16. Christadoss P., Lindstrom J. M., Melvold R. W., Talal N. Mutation at I-A beta chain prevents experimental autoimmune myasthenia gravis. Immunogenetics. 21:1985;33-38.
17. bm12+. J. Immunol. 147:1991;1484-1491.
18. Bellone M., Ostlie N., Lei S., Conti-Tronconi B. M. Experimental myasthenia gravis in congenic mice. Sequence mapping and H-2 restriction of T helper epitopes on the α subunits ofTorpedo californica. Eur. J. Immunol. 21:1991;2303-2310.
19. Infante A. J., Thompson P. A., Krolick K. A., Wall K. A. Determinant selection in murine experimental autoimmune myasthenia gravis. Effect of the bm12 mutation on T cell recognition of acetylcholine receptor epitopes. J. Immunol. 146:1991;2977-2982.
20. McIntyre K., Seidman J. Nucleotide sequence of mutant I-A beta bm12 gene is evidence for genetic exchange between mouse immune response genes. Nature. 308:1984;551-553.
21. Infante A. J., Levcovitz H., Gordon V., Wall K. A., Thompson P. A., Krolick K. A. Preferential use of a T cell receptor Vβ gene by acetylcholine receptor reactive T cells from myasthenia gravis-susceptible mice. J. Immunol. 148:1992;3385-3390.
22. Infante A. J., Faler J., Chang S., Currier P., Thompson P., Krolick K., Zborowski K., Kraig E. T-cell receptor expression in murine myasthenia gravis. Ann. NY. Acad. Sci. 681:1993;292-294.
23. bm12. Scand. J. Immunol. 42:1995;215-225.
24. Osman G. E., Toda M., Kanagawa O., Hood L. E. Characterization of the T cell receptor repertoire causing collagen arthritis in mice. J. Exp. Med. 177:1993;387-395.
25. Shenoy M., Oshima M., Atassi M. Z., Christadoss P. Suppression of experimental autoimmune myasthenia gravis by epitope-specific neonatal tolerance to synthetic region α146-162 of acetylcholine receptor. Clin. Immunol. Immunopathol. 66:1993;230-238.
26. Lodge P. A., Allegretta M., Steinman L., Sriram S. Myelin basic protein peptide specificity and T cell receptor gene usage of HPRT mutant T cell clones in patients with multiple sclerosis. Ann. Neurol. 36:1994;734-740.
27. Okumura S., McIntosh K., Drachman D. B. Oral administration of acetylcholine receptor: effects on experimental myasthenia gravis. Ann. Neurol. 36:1994;704-713.
28. Eldefrawi M. E., Eldefrawi A. T. Purification and molecular properties of the acetylcholine receptor fromTorpedo electroplax. Arch. Biochem. Biophys. 159:1973;362-372.
29. Yokoi T., Mulac-Jericevic B., Kurisaki J., Atassi M. Z. T lymphocyte recognition of acetylcholine receptor: Localization of the full T cell recognition profile on the extracellular part of the α chain of Torpedo californica acetylcholine receptor. Eur. J. Immunol. 17:1987;1697-1702.
30. Claudio T., Ballivet M., Patrick J., Heinemann S. Nucleotide and deduced amino acid sequences ofTorpedo californica. Proc. Natl. Acad. Sci. USA. 80:1983;1111-1115.
31. Krco C. J., David C. S., Lennon V. A. Mouse T lymphocyte response to acetylcholine receptor determined by T cell receptor for antigen Vβ gene products recognizing Mls-a. J. Immunol. 147:1992;3303-3305.
32. Kappler J. W., Skidmore B., White J., Marrack P. Antigen-inducible, H-2-restricted, interleukin-2-producing T cell hybridomas. Lack of independent antigen and H-2 recognition. J. Exp. Med. 153:1981;1198-1214.
33. Born W., White J., O'Brien R., Kubo R. Development of T cell receptor expression: Studies using T cell hybridomas. Immunol. Res. 7:1988;279-291.
34. Kruisbeek A. M. Production of mouse T cell hybridomas. Current Protocols in Immunology. 1994;John Wiley & Sons, New York. p. 3.14.1-3.14.11.
35. Chomczynski P., Sacchi N. Single step method of RNA isolation by acid guanidinum-thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:1987;156-159.
36. Yang B., Yolken R., Viscidi R. Quantitative polymerase chain reaction by monitoring enzymatic activity of DNA polymerase. Anal. Biochem. 208:1993;110-116.
37. Sanger F., Nicklen S., Coulson A. R. DNA sequencing with chain terminating inhibitors. Proc. Natl. Acad. Sci. USA. 74:1977;5463-5466.
38. Rock E. P., Sibbald P. R., Davis M. M., Chien Y. CDR3 length in antigen-specific immune receptors. J. Exp. Med. 179:1994;323-328.
39. McIntosh K. R., Drachman D. B. Tolerance to acetylcholine receptor induced by AChR-coupled syngeneic cells. J. Neuroimmunol. 38:1992;75-84.
40. bm12. J. Immunol. 145:1990;94-101.
41. Cohen P. L., Creech E., Nakui-Aquaronne D., McDaniel R., Ackler S., Rapoport R. G., Sobel E. S., Eisenberg R. A. Antigen non-specific effect of major histocompatibility complex haplotype on autoantibody levels in systemic lupus erythematosus pronelpr. J. Clin. Invest. 91:1993;2762-2767.
42. Pierce J. L., Zborowski K. A., Kraig E., Infante A. J. Highly conserved TCR β chain CDR3 sequences among immunodominant acetylcholine receptor-reactive T cells in murine myasthenia gravis. International Immunol. 6:1994;775-783.
43. Kraig E., Pierce J. L., Clarkin K. Z., Standifer N. E., Currier P., Wall K. A., Infante A. J. Restricted T cell receptor repertoire for acetylcholine receptor in murine myasthenia gravis. J. Neuroimmunol. 71:1996;87-95.
44. Wu B., Shenoy M., Goluszko E., Kaul R., Christadoss P. TCR gene usage in experimental autoimmune myasthenia gravis pathogenesis usage of multiple TCRBV. J. Immunol. 154:1995;3603-3610.
45. Jorgensen J. L., Esser U., Fazekas S., Groth B., Reay P. A., Davis M. M. Mapping T-cell receptor-peptide contacts by variant peptide immunization of single-chain transgenics. Nature. 355:1992;224-230.
46. Chien Y., Davis M. M. Howα/β T cell receptors "see" peptide/MHC complexes. Immunol. Today. 14:1993;597-602.
47. b. J. Immunol. 152:1994;4526-4536.
48. βTorpedo. J. Immunol. 154:1995;5245-5254.
49. Thompson P. A., McAtee R., Infante A. J., Currier P., Beninati W., Krolick K. A. Vβ-specific immunotoxin selectively kills acetylcholine receptor-reactive lymphocytes from mice with experimental autoimmune myasthenia gravis. Int. Immunol. 6:1994;1807-1815.
50. Dau P. C., Lindstrom J. M., Cassel C. K., Clark E. C. Plasmapheresis in myasthenia gravis and polymyositis. Dau P. C. Plasmapheresis and the Immunobiology of Myasthenia Gravis. 1979;229-247 Houghton Mifflin, Boston.
51. Mosmann T. R., Coffman R. L. Th1 and Th2 cells: Different patterns of lymphokine secretion lead to different functional properties. Annu. Rev. Immunol. 7:1989;145-173.
52. Nicholson L. B., Greer J. M., Sobel R. A., Lees M. B., Kuchroo V. K. An altered peptide ligand mediates immune deviation and prevents autoimmune encephalomyelitis. Immunity. 3:1995;397-405.
53. Windhagen A., Scholz C., Hollsberg P., Fukaura H., Sette A., Hafler D. A. Modulation of cytokine patterns of human autoreactive T cell clones by a single amino acid substitution of their peptide ligand. Immunity. 2:1995;373-380.
54. Chaturvedi P., Yu Q., Southwood S., Sette A., Singh B. Peptide analogs with different affinities for MHC alter the cytokine profile of T helper cells. Int. Immunol. 8:1996;745-755.
55. Palmer M., Sercarz E. Determinant preferences in the relationship between T and B cells specific for lysozyme. Smith-Gill S., Sercarz E. The Immune Response to Structurally Defined Proteins: The Lysozyme Model. 1989;285 Adenine Press, Boston.
56. Bellone M., Karachunski P. I., Ostlie N., Lei S., Conti-Tronconi B. M. Preferential pairing of T and B cells for production of antibodies without covalent association of T and B epitopes. Eur. J. Immunol. 24:1994;799-804.
57. Yeh T-M., Krolick K. A. T cells reactive with a small synthetic peptide of the acetylcholine receptor can provide help for a clonotypically heterogeneous antibody response and subsequently impaired muscle function. J. Immunol. 144:1990;1654-1660.
58. Wang K., Klotz J. L., Kiser G., Bristol G., Hays E., Lai E., Gese E., Kronenberg M., Hood L. Organization of the V gene segments in mouse T cell antigen receptor alpha/delta locus. Genomics. 20:1994;419-428.
59. Koop B. F., Rowen L., Wang K., Kuo C. L., Seto D., Lenstra J. A., Howard S., Shan W., Deshpande P., Hood L. The human T-cell receptor TCRAC/TCRDC (Cα/Cδ) region: Organization, sequence, and evolution of 97.6 kb of DNA. Genomics. 19:1994;478-493.
60. Wilson R. K., Lai E., Concannon P., Barth R. K., Hood L. E. Structure, organization and polymorphism of murine and human T-cell receptor α and β chain gene families. Immunol. Rev. 101:1988;149-172.
61. Pannetier C., Cochet M., Darche S., Casrouge A., Zoller M., Kourilsky P. The sizes of the CDR3 hypervariable regions of the murine T cell receptor β chains vary as a function of the recombined germ-line segments. Proc. Natl. Acad. Sci. USA. 90:1990;4319-4323.